Loss of hepatitis A virus antibodies after bone marrow transplantation

Bone Marrow Transplantation

Volumn 38, Issue 1, 2006, Pages 37-40

  Godoi, E R ^a   de Souza, V A U F ^a   Cakmak, S ^b   Machado, A F ^a   Vilas Boas, L S ^a   Machado, C M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b HEALTH CANADA   (Canada)

Author keywords

Antibody loss; Epidemiology; Hepatitis A; Seroprevalence; Vaccination

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; MELPHALAN;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGE DISTRIBUTION; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD SAMPLING; BRAZIL; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS A; HUMAN; IMMUNIZATION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; RETROSPECTIVE STUDY; SCREENING TEST;

EID: 33745263929     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705391     Document Type: Article

References (12)

1. Debray D, Cullufi P, Devictor D, Fabre M, Bernard O. Liver failure in children with hepatitis A. Hepatology 1997; 26: 1018-1022.
2. Vitral CL, Yoshida CF, Lemos ER, Teixeira CS, Gaspar AM. Age-specific prevalence of antibodies to hepatitis A in children and adolescents from Rio de Janeiro, Brazil, 1978 and 1995. Relationship of prevalence to environmental factors. Mem Inst Oswaldo Cruz 1998; 93: 1-5.
3. Tanaka J. Hepatitis A shifting epidemiology in Latin America. Vaccine 2000; 18 (Suppl 1): S57-S60.
4. Ljungman P, Engelhard D, de la Camara R, Einsele H, Locasciulli A, Martino R et al. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Vaccination of stem cell transplant recipients: Recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 2005; 35: 737-746.
5. Dignani MC, Miceli MH, Rosa CM, Gatica J, Martínez-Rolón J, Pizzolato M. Loss of hepatitis A virus (HAV) antibodies after peripheral stem cell transplantation (PSCT). Bone Marrow Transplant 2003; 31: 809-812.
6. Glode MP, Evans GS, Fleming DW, Guerra FA, Le CT, Offit PA. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1999; 48: 1-37.
7. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141-1154.
8. Ljungman P, Duraj V, Magnius L. Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant 1991; 7: 89-93.
9. Hammarstrom V, Pauksen K, Bjorkstrand B, Simonsson B, Oberg G, Ljungman P. Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients. Bone Marrow Transplant 1998; 22: 67-71.
10. Parkkali T, Ruutu T, Stenvik M, Kuronen T, Kayhty H, Hovi T et al. Loss of protective immunity to polio, diphtheria and haemophilus influenzae type b after allogeneic bone marrow transplantation. APMIS 1996; 104: 383-388.
11. Machado CM, Gonçalves FB, Pannuti CS, Dulley FL, Souza VAUF. Measles in bone marrow transplant recipients during an outbreak in São Paulo, Brazil. Blood 2002; 99: 83-87.
12. Pauksen K, Linde A, Ljungman P, Bolme P, Lonnerholm G, Oberg G et al. Specific T and B cell immunity to measles after allogeneic and autologous bone marrow transplantation. Bone Marrow Transplant 1995; 16: 807-813.